Muvalapline (tetrahydrochloride)

Muvalaplin tetrahydrochloride (LY3473329) is an orally active reagent of lipoprotein (a) (Lp (a) ) . At present, research on Muvalaplin tetrahydrochloride oral reagent is ongoing[1].

2565656-71-3

LY3473329 (tetrahydrochloride)

12352005

PAI-1

Metabolic Enzyme/Protease

Neuroscience-Neuromodulation

Cardiovascular Disease

99.55

H2O : ≥ 100 mg/mL

OC([C@H]([C@H]1CCNC1)CC2=CC(CN(CC3=CC(C[C@@H]([C@H]4CCNC4)C(O)=O)=CC=C3)CC5=CC(C[C@@H]([C@H]6CCNC6)C(O)=O)=CC=C5)=CC=C2)=O.[H]Cl.[H]Cl.[H]Cl.[H]Cl

C42H58Cl4N4O6

856.75

[1]Bhatia HS, et al. Lipoprotein (a) : Evidence for Role as a Causal Risk Factor in Cardiovascular Disease and Emerging Therapies. J Clin Med. 2022 Oct 13;11 (20) :6040.

Room Temperature

4°C (Powder, sealed storage, away from moisture)

http://file.medchemexpress.com/batch_PDF/HY-46749/Muvalaplin-tetrahydrochloride-SDS-MedChemExpress.pdf

Reference compound1

Phase 2